Analyst picks & changes

Centocor Inc.


Discussion of competing therapies at the American College of Cardiology meeting last week underscored worries about


's slow market launch in high risk angioplasty.

Cowen's Stone said he was hearing consistent "yellow lights"

Read the full 375 word article

How to gain access

Continue reading with a
two-week free trial.